US 12377135
GHRH antagonists for use in a method of treating sarcoidosis
granted A61KA61K38/16A61K38/25
Quick answer
US patent 12377135 (GHRH antagonists for use in a method of treating sarcoidosis) held by United States Government as represented by the Department of Veterans Affairs expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Government as represented by the Department of Veterans Affairs
- Grant date
- Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/16, A61K38/25, A61P, A61P11/00